查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2023-2030年全球血管内支架市场
市场调查报告书
商品编码
1380412

2023-2030年全球血管内支架市场

Global Intravascular Stents Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 175 Pages | 商品交期: 2-3个工作天内

价格

预计全球血管内支架市场在预测期（2023-2030年）将以9.4%的CAGR成长。关键因素包括週边血管疾病（PVD）和冠状动脉疾病（CAD）盛行率的增加。据世界卫生组织 (WHO) 称，心血管疾病 (CVD) 是全球主要死亡原因，每年估计夺走 1,790 万人的生命。此外，血管内支架的协议和收购的增加预计将透过促进这些设备的接受和使用的增加来推动市场成长。 2021年12月，健康科技先驱皇家飞利浦签署协议，收购美国开发微创週边血管设备的医疗科技公司Vesper Medical Inc.。 Vesper Medical 透过用于治疗深部静脉疾病的先进静脉支架产品组合进一步扩展了飞利浦的诊断和治疗设备产品组合。

细分市场前景

全球血管内支架市场按产品、输送方式和最终用户进行细分。根据类型，市场分为冠状动脉支架、神经血管支架、週边支架、肾动脉支架和主动脉支架。根据输送方式，市场分为自扩张支架和球囊扩张支架。此外，根据最终用户，市场细分为医院、心臟中心和门诊手术中心。在最终用户中，医院和心臟中心细分市场由于设备齐全、易于使用、高度信任和可靠性，预计将占据相当大的市场份额。

预计冠状动脉支架细分市场将在全球血管内支架市场中占据相当大的份额

其中，冠状动脉支架细分市场预计将在全球血管内支架市场中占据相当大的份额。节段性增长归因于冠心病（CAD）盛行率的增加，当斑块在动脉中积聚时就会发生冠心病，导致对涉及支架的经皮冠状动脉介入治疗的需求不断增长。根据国家医学图书馆的研究，Rao 等人所做的系统性回顾。研究表明，城市地区 CAD 盛行率为 2.5-12.6%，农村地区为 1.4-4.6%。此外，美国食品药物管理局 (FDA) 批准的产品数量不断增加也促进了冠状动脉支架的采用。例如，2022 年 5 月，美国 FDA 批准美敦力公司的药物洗脱支架 (DES) Onyx Frontier 用于治疗 CAD 患者。新的 DES 产品利用与美敦力 Resolute Onyx 相同的平台，旨在改善药物输送并提高急性表现。

区域展望

全球血管内支架市场根据地理位置进一步细分，包括北美（美国和加拿大）、欧洲（英国、义大利、西班牙、德国、法国和欧洲其他地区）、亚太地区（印度、中国、日本） 、韩国和亚洲其他地区）以及世界其他地区（中东和非洲以及拉丁美洲）。其中，由于心血管疾病的盛行率不断上升以及生活方式的改变，预计亚太地区将在全球市场中占据显着份额。

北美地区预计全球血管内支架市场复合CAGR显着成长

在所有地区中，北美地区预计在预测期内将以相当大的CAGR成长。推动北美市场的主要因素是北美地区心血管疾病数量的增加，预计将对未来几年支架市场的成长产生积极影响。慢性病患者数量的增加预计将推动经皮冠状动脉介入治疗和周边血管手术的需求。根据美国心臟协会 (AHA) 的数据，心血管疾病仍然是美国的首要死因，2020 年死亡人数为 928,741 人。2020 年，冠心病 (CHD) 是美国的首要死因（41.2%）在美国，CVD 导致的死亡最多，其次是中风(17.3%)、其他CVD (16.8%)、高血压(12.9%)、心臟衰竭(9.2%) 和动脉疾病(2.6%)。

市场参与者展望

服务全球血管内支架市场的主要公司包括： Abbott Laboratories、B. Braun SE、Boston Scientific Corp.、Medtronic plc、Terumo Corp.等。市场参与者透过各种策略（包括併购、合作、合作、融资和新产品发布），为市场成长做出了巨大贡献，以保持市场竞争力。例如，2022 年 11 月，波士顿科学公司收购了 WOLF 血栓切除术 (R) 平台的开发商 Devoro Medical, Inc.，将机械血栓切除术平台添加到週边干预产品组合中。创新的非控制台和非溶解的 WOLF 技术使用手指状尖头瞄准并快速捕获血块，检索和清除动脉和静脉系统中的血栓。

报告涵盖：

  • 2022年市场价​​值资料分析及2030年预测。
  • 每个细分市场的年化市场收入（百万美元）。
  • 主要地理区域的国家分析。
  • 全球血管内支架市场的主要公司。根据现有资料，报告中还提供了与新产品发布相关的资讯以及相关新闻。
  • 透过确定未来强劲成长的关键细分市场来分析业务策略。
  • 市场进入和市场扩张策略分析。
  • 透过识别市场中「谁的立场」来制定竞争策略。

目录

第 1 章：报告摘要

  • 目前行业分析及成长潜力展望
  • 研究方法和工具
  • 市场区隔
    • 按细分
    • 按地区

第 2 章：市场概述与见解

  • 报告范围
  • 分析师见解和当前市场趋势
    • 主要发现
    • 建议
    • 结论

第 3 章：竞争格局

  • 主要公司分析
  • B. Braun SE
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Medtronic plc
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Terumo Corp.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Stryker Corp.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • 关键策略分析

第 4 章：市场细分

  • 按产品分類的全球血管内支架市场
    • 冠状动脉支架
    • 神经血管支架
    • 外周支架
    • 肾动脉支架
    • 主动脉支架
  • 以输送方式分類的全球血管内支架市场
    • 自膨式支架
    • 球囊扩张支架
  • 按最终用户分類的全球血管内支架市场
    • 医院和心臟中心
    • 门诊手术中心

第 5 章：区域分析

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 世界其他地区

第 6 章：公司简介

  • Abbott Laboratories
  • BIOTRONIK SE & Co KG
  • Boston Scientific Corp.
  • Cook Group Inc.
  • Elixir Medical Corp.
  • Hellman & Friedman LLC
  • Integer Holdings Corp.
  • iVascular, SLU
  • LifeTech Scientific Corp.
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corp.
  • Stentys S.A.
  • Vascular Concepts Ltd.
  • Veryan Holdings Ltd.
  • VESALIO, LLC
Product Code: OMR2027821

Title: Global Intravascular Stents Market Size, Share & Trends Analysis Report by Product (Coronary Stents, Neurovascular Stents, Peripheral Stents, Renal Artery Stents, and Aortic Stents), by Mode of Delivery (Self-Expanding Stents and Balloon-Expandable Stents), by End-User (Hospitals and Cardiac Centers and Ambulatory Surgical Centers),Forecast Period (2023-2030).

The global intravascular stents market is anticipated to grow at a CAGR of 9.4% during the Forecast Period (2023-2030). Pivotal factors including the increasing prevalence of peripheral vascular diseases (PVDs) and coronary artery diseases (CAD). According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year. Further, the increasing agreement and acquisition for intravascular stents is projected to drive market growth by promoting increased acceptance and usage of these devices. In December 2021, Royal Philips, a pioneer in health technology signed an agreement to acquire Vesper Medical Inc., a US-based medical technology company that developed minimally invasive peripheral vascular devices. Vesper Medical further expanded Philips' portfolio of diagnostic and therapeutic devices with an advanced venous stent portfolio for the treatment of deep venous disease.

Segmental Outlook

The global intravascular stents market is segmented on the product, mode of delivery and end-user. Based on the type, the market is sub-segmented into coronary stents, neurovascular stents, peripheral stents, renal artery stents and aortic stents. Based on the mode of delivery, the market is sub-segmented into self-expanding stents and balloon-expandable stents. Further, based on end-user, the market is sub-segmented into hospitals and cardiac centers and ambulatory surgical centers. Among the end-user, the hospitals and cardiac centers sub-segment is anticipated to hold a considerable share of the market, owing to the well-equipped settings, easy availability, high trust, and reliability.

The Coronary Stents Sub-Segment is Anticipated to Hold a Considerable Share of the Global Intravascular Stents Market

Among the product, the coronary stents sub-segment is expected to hold a considerable share of the global intravascular stents market. The segmental growth is attributed to the increasing prevalence of CADs, which occur when plaque accumulates in the arteries, has led to a growing demand for percutaneous coronary intervention treatments involving stents. According to the study of National Library of Medicine, the systematic review done by Rao et al. demonstrated that prevalence of CAD in urban areas was 2.5-12.6% and in rural areas, 1.4-4.6%. Additionally, the rising number of Food and Drug Administration (FDA) approvals of the products are also contributing to the increasing adoption for coronary stents. For instance, in May 2022, the US FDA approved drug-eluting stent (DES) Onyx Frontier, from Medtronic, for the treatment of patients with CAD. The new DES product leverages the same platform as Medtronic's Resolute Onyx, designed to improve the delivery of drugs and improve acute performance.

Regional Outlook

The global intravascular stents market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to the increasing prevalence of CVDs, and the and changes in lifestyles.

The North America Region is Expected to Grow at a Significant CAGR in the Global Intravascular Stents Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. The major factors driving the North America market is the increasing number of cardiovascular disorders across the North America is estimated to positively impact the stents market growth in upcoming years. Increasing patient pool with chronic diseases is expected to drive the demand for percutaneous coronary intervention and peripheral vascular procedures. According to the American Heart Association (AHA), CVDs remains as the leading cause of death in the US, accounted for 928,741 mortalities in the year 2020. In 2020 in the US, coronary heart disease (CHD) was the leading cause (41.2%) of deaths attributable to CVD in the US, followed by stroke (17.3%), other CVD (16.8%), high blood pressure (12.9%), heart failure (9.2%), diseases of the arteries (2.6%).

Market Players Outlook

The major companies serving the global intravascular stents market include: Abbott Laboratories, B. Braun SE, Boston Scientific Corp., Medtronic plc, Terumo Corp., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in November 2022, Boston Scientific Corp., acquired the Devoro Medical, Inc., developer of the WOLF Thrombectomy® Platform, to add mechanical thrombectomy platform to peripheral interventions portfolio. The innovative non-console and lytic-free WOLF technology targets and rapidly captures blood clots using finger-like prongs that retrieve and remove thrombi in the arterial and venous systems.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global intravascular stents market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. B. Braun SE
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Medtronic plc
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Terumo Corp.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Stryker Corp.
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Intravascular Stents Market by Product
    • 4.1.1. Coronary Stents
    • 4.1.2. Neurovascular Stents
    • 4.1.3. Peripheral Stents
    • 4.1.4. Renal Artery Stents
    • 4.1.5. Aortic Stents
  • 4.2. Global Intravascular Stents Market by Mode of Delivery
    • 4.2.1. Self-Expanding Stents
    • 4.2.2. Balloon-Expandable Stents
  • 4.3. Global Intravascular Stents Market by End-User
    • 4.3.1. Hospitals and Cardiac Centers
    • 4.3.2. Ambulatory Surgical Centers

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Abbott Laboratories
  • 6.2. BIOTRONIK SE & Co KG
  • 6.3. Boston Scientific Corp.
  • 6.4. Cook Group Inc.
  • 6.5. Elixir Medical Corp.
  • 6.6. Hellman & Friedman LLC
  • 6.7. Integer Holdings Corp.
  • 6.8. iVascular, SLU
  • 6.9. LifeTech Scientific Corp.
  • 6.10. Meril Life Sciences Pvt. Ltd.
  • 6.11. MicroPort Scientific Corp.
  • 6.12. Stentys S.A.
  • 6.13. Vascular Concepts Ltd.
  • 6.14. Veryan Holdings Ltd.
  • 6.15. VESALIO, LLC

LIST OF TABLES

  • 1. GLOBAL INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 2. GLOBAL CORONARY STENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL NEUROVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL PERIPHERAL STENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL RENAL ARTERY STENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL AORTIC STENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY MODE OF DELIVERY, 2022-2030 ($ MILLION)
  • 8. GLOBAL SELF-EXPANDING INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL BALLOON-EXPANDABLE INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 11. GLOBAL INTRAVASCULAR STENTS FOR HOSPITALS AND CARDIAC CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL INTRAVASCULAR STENTS FOR AMBULATORY SURGICAL CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. NORTH AMERICAN INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY MODE OF DELIVERY, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 18. EUROPEAN INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 19. EUROPEAN INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 20. EUROPEAN INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY MODE OF DELIVERY, 2022-2030 ($ MILLION)
  • 21. EUROPEAN INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 22. ASIA-PACIFIC INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 23. ASIA-PACIFIC INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 24. ASIA-PACIFIC INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY MODE OF DELIVERY, 2022-2030 ($ MILLION)
  • 25. ASIA-PACIFIC INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 26. REST OF THE WORLD INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY MODE OF DELIVERY, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL INTRAVASCULAR STENTS MARKET SHARE BY PRODUCT, 2022 VS 2030 (%)
  • 2. GLOBAL CORONARY STENTS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL NEUROVASCULAR STENTS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL PERIPHERAL STENTS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL RENAL ARTERY STENTS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL AORTIC STENTS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL INTRAVASCULAR STENTS MARKET SHARE BY MODE OF DELIVERY, 2022 VS 2030 (%)
  • 8. GLOBAL SELF-EXPANDING INTRAVASCULAR STENTS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL BALLOON-EXPANDABLE INTRAVASCULAR STENTS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL INTRAVASCULAR STENTS MARKET SHARE BY END-USER, 2022 VS 2030 (%)
  • 11. GLOBAL INTRAVASCULAR STENTS FOR HOSPITALS AND CARDIAC CENTERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL INTRAVASCULAR STENTS FOR AMBULATORY SURGICAL CENTERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL INTRAVASCULAR STENTS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. US INTRAVASCULAR STENTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. CANADA INTRAVASCULAR STENTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. UK INTRAVASCULAR STENTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. FRANCE INTRAVASCULAR STENTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. GERMANY INTRAVASCULAR STENTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. ITALY INTRAVASCULAR STENTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. SPAIN INTRAVASCULAR STENTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. REST OF EUROPE INTRAVASCULAR STENTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. INDIA INTRAVASCULAR STENTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. CHINA INTRAVASCULAR STENTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. JAPAN INTRAVASCULAR STENTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. SOUTH KOREA INTRAVASCULAR STENTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. REST OF ASIA-PACIFIC INTRAVASCULAR STENTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD INTRAVASCULAR STENTS MARKET SIZE, 2022-2030 ($ MILLION)